Trials / Completed
CompletedNCT04817644
A Research Study to See How Much Semaglutide and SNAC is in the Milk of Healthy, Breastfeeding Women Taking Semaglutide Tablets
A Trial Investigating Semaglutide and SNAC Concentrations in Breastmilk Following Administration of Multiple Doses of Oral Semaglutide in Healthy, Lactating Females
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Participants in the study, will receive the study drug once daily for 10 days in tablet form for oral (by mouth) intake. On day 1 to 5 the tablet will contain 3 mg semaglutide, and on day 6-10 the tablet will contain 7 mg semaglutide.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oral semaglutide | Oral semaglutide once daily for a total of 10 days |
Timeline
- Start date
- 2021-09-10
- Primary completion
- 2023-05-26
- Completion
- 2023-07-03
- First posted
- 2021-03-26
- Last updated
- 2025-03-11
Locations
2 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04817644. Inclusion in this directory is not an endorsement.